top of page

AAP releases guidelines on evaluating, treating children and adolescents with obesity

The American Academy of Pediatrics (AAP) has published its first comprehensive guidance in 15 years that highlights more evidence than ever that obesity treatment is safe and effective. Evidence-based recommendations on medical care for those age 2 and older are included within a new “Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity,” published in the February 2023 Pediatrics (published online January 9 2023). The guideline is accompanied by an executive summary and two technical reports, “Appraisal of Clinical Care Practices for Child Obesity Treatment. Part I: Interventions,” and “Appraisal of Clinical Care Practices for Child Obesity Treatment. Part II: Comorbidities.”

“Weight is a sensitive topic for most of us, and children and teens are especially aware of the harsh and unfair stigma that comes with being affected by it,” said Dr Sarah Hampl, a lead author of the guideline, created by a multidisciplinary group of experts in various fields, along with primary care providers and a family representative, and chair of the Clinical Practice Guideline Subcommittee on Obesity. “Research tells us that we need to take a close look at families - where they live, their access to nutritious food, health care and opportunities for physical activity -as well as other factors that are associated with health, quality-of- life outcomes and risks. Our kids need the medical support, understanding and resources we can provide within a treatment plan that involves the whole family.”

The AAP guideline contains key action statements, which represent evidence-based recommendations for evaluating and treating children with overweight and obesity and related health concerns. These recommendations include motivational interviewing, intensive health behaviour and lifestyle treatment, pharmacotherapy and metabolic and bariatric surgery. The approach considers the child’s health status, family system, community context, and resources.


The guideline discusses increased risks for children with special health care needs, as well as inequities that promote obesity in childhood, such as the marketing of unhealthy food, low socioeconomic status and household food insecurity. The role of structural racism has played in obesity prevalence is also discussed.


The guideline does not discuss obesity prevention, which will be addressed in another forthcoming AAP policy statement. The AAP describes the role of a primary care physician – or medical home -- in overseeing intensive and long-term care strategies, ongoing medical monitoring, and treatment of youth with obesity.


“There is no evidence that ‘watchful waiting’ or delayed treatment is appropriate for children with obesity,” said Dr Sandra Hassink, an author of the guideline and vice chair of the Clinical Practice Guideline Subcommittee on Obesity. “The goal is to help patients make changes in lifestyle, behaviours or environment in a way that is sustainable and involves families in decision-making at every step of the way.”


Key action statements guide physicians on how to evaluate children and teens for obesity. The AAP also recommends:

  • Comprehensive obesity treatment may include nutrition support, physical activity treatment, behavioural therapy, pharmacotherapy, and metabolic and bariatric surgery.

  • Intensive health behaviour and lifestyle treatment (IHBLT), while challenging to deliver and not universally available, is the most effective known behavioural treatment for child obesity. The most effective treatments include 26 or more hours of face-to-face, family-based, multicomponent treatment over a 3- to 12-month period.

  • Evidence-based treatment delivered by trained health care professionals with active parent or caregiver involvement has no evidence of harm and can result in less disordered eating.

  • Physicians should offer adolescents ages 12 years and older with obesity weight loss pharmacotherapy, according to medication indications, risks, and benefits, as an adjunct to health behaviour and lifestyle treatment.

  • Teens age 13 and older with severe obesity (BMI ≥120% of the 95th percentile for age and sex) should be evaluated for metabolic and bariatric surgery.

The AAP encourages strong promotion of supportive payment and public health policies that cover comprehensive obesity prevention, evaluation and treatment. The guideline calls for policy changes within and beyond the health sector to improve health and wellbeing of children. Policy changes should address structural racism that drives alarming and persistent disparities in childhood obesity, according to the guideline’s executive report.

“The medical costs of obesity on children, families and our society as a whole are well-documented and require urgent action,” added Hampl. “This is a complex issue, but there are multiple ways we can take steps to intervene now and help children and teens build the foundation for a long, healthy life.”

To access the guidelines, please click here

コメント


bottom of page